Indivior PLC
LSE:INDV

Watchlist Manager
Indivior PLC Logo
Indivior PLC
LSE:INDV
Watchlist
Price: 794.5 GBX 0.57%
Market Cap: 1B GBX
Have any thoughts about
Indivior PLC?
Write Note

Indivior PLC
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Indivior PLC
Cash Equivalents Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Indivior PLC
LSE:INDV
Cash Equivalents
$302m
CAGR 3-Years
-33%
CAGR 5-Years
-21%
CAGR 10-Years
39%
GlaxoSmithKline PLC
LSE:GSK
Cash Equivalents
ÂŁ3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Cash Equivalents
$6.9B
CAGR 3-Years
-24%
CAGR 5-Years
5%
CAGR 10-Years
3%
Verona Pharma PLC
NASDAQ:VRNA
Cash Equivalents
$336m
CAGR 3-Years
26%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash Equivalents
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Indivior PLC's Cash Equivalents?
Cash Equivalents
302m USD

Based on the financial report for Jun 30, 2024, Indivior PLC's Cash Equivalents amounts to 302m USD.

What is Indivior PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
39%

Over the last year, the Cash Equivalents growth was -49%. The average annual Cash Equivalents growth rates for Indivior PLC have been -33% over the past three years , -21% over the past five years , and 39% over the past ten years .

Back to Top